Skip to content
StockMarketAgent
Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

AIM/CRW stock hub

AIM/CRW has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/CRWis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
531.1M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/CRW
In the news

Latest news · AIM/CRW

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.4
P25 12.9P50 16.9P75 23.5
Trailing P/E33.1
P25 15.9P50 22.9P75 35.8
ROE6.7
P25 -54.2P50 2.1P75 13.7
ROIC7.1
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/CRW market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
243
Groups with data
11
Currency
USD
Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
765
Employees Change
18%
Employees Change Percent
2.41
Enterprise value
GBX 520.6M
Exchange
London Stock Exchange AIM
Financial currency
USD
First seen
2026-05-10
Industry
Medical - Healthcare Information Services
Isin
GB00B2425G68
Last refreshed
2026-05-10
Market cap
GBX 531.1M
Price
GBX 1,546
Price currency
GBX
Rev Per Employee
205,256.42x
Sector
Healthcare
Sic
7372
Symbol
aim/CRW
Website
https://www.thecranewaregroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.14%
EV Earnings
31.18x
EV/EBIT
25.25x
EV/EBITDA
22.76x
EV/FCF
71.31x
EV/Sales
3.32x
FCF yield
1.37%
Forward P/E
16.37x
P/B ratio
2.11x
P/E ratio
33.14x
P/S ratio
3.38x
PE Ratio10 Y
73.8x
PE Ratio3 Y
54.13x
PE Ratio5 Y
65.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
13.13%
EBITDA Margin
14.21%
FCF margin
4.65%
Gross margin
86.15%
Gross Profit
GBX 135.3M
Gross Profit Growth
1.55%
Gross Profit Growth Q
3.2%
Gross Profit Growth3 Y
3.93%
Gross Profit Growth5 Y
4.17%
Net Income
GBX 16.7M
Net Income Growth
51.1%
Net Income Growth Q
38.88%
Net Income Growth Quarters
6%
Net Income Growth Years
2%
Net Income Growth3 Y
24.3%
Net Income Growth5 Y
19.48%
Pretax Margin
12.71%
Profit Margin
10.64%
Profit Per Employee
GBX 21,830
Profitable Years
21
ROA
3.18
Roa5y
3.2
ROCE
7.08
ROE
6.72
Roe5y
4.66
ROIC
7.14
Roic5y
19.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

29
MetricValue
Cagr10y
8.42%
Cagr15y
9.09%
Cagr1y
-12.94%
Cagr3y
2.67%
Cagr5y
-9.29%
Div CAGR10
8.22%
Div CAGR3
6.16%
Div CAGR5
4.41%
EPS Growth
48.88
EPS Growth Q
37.56
EPS Growth Quarters
6
EPS Growth Years
2
EPS Growth3 Y
23.67
EPS Growth5 Y
19.2
FCF Growth
-85.68%
FCF Growth Q
-87.15%
FCF Growth3 Y
-37.72%
FCF Growth5 Y
-36.9%
OCF Growth
-85.27%
OCF Growth Q
-86.76%
OCF Growth10 Y
-9.36%
OCF Growth3 Y
-37.46%
OCF Growth5 Y
-36.45%
Revenue Growth
6.68x
Revenue Growth Q
5.67x
Revenue Growth Quarters
13x
Revenue Growth Years
20x
Revenue Growth3 Y
3.74x
Revenue Growth5 Y
3.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
GBX 0.39
Assets
GBX 390.5M
Cash
GBX 30.4M
Current Assets
GBX 75.6M
Current Liabilities
GBX 97.8M
Debt
GBX 20M
Debt EBITDA
GBX 0.87
Debt Equity
GBX 0.08
Debt FCF
GBX 2.74
Equity
GBX 252.2M
Interest Coverage
12.81
Liabilities
GBX 138.3M
Long Term Assets
GBX 314.9M
Long Term Liabilities
GBX 40.5M
Net Cash
GBX 10.4M
Net Cash By Market Cap
GBX 1.96
Net Cash Growth
-61.28%
Net Debt EBITDA
GBX -0.47
Net Debt Equity
GBX -0.04
Net Debt FCF
GBX -1.43
Tangible Book Value
GBX -54.9M
Tangible Book Value Per Share
GBX -1.56
WACC
3.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.77
Net Working Capital
GBX -52.3M
Quick ratio
0.68
Working Capital
GBX -22.5M
Working Capital Turnover
GBX -3.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-1.34%
Dividend Growth
13.56%
Dividend Growth Years
18%
Dividend per share
GBX 0.34
Dividend Years
19
Dividend Yield
2.17%
Ex Div Date
2026-03-19
Last Dividend
GBX 0.15
Payout Frequency
Semi-Annual
Payout Ratio
66.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
124.38%
1Y total return
-12.93%
200-day SMA
1,920.5
3Y total return
8.24%
50-day SMA
1,451.5
50-day SMA vs 200-day SMA
50under200
5Y total return
-38.57%
All Time High
3,650
All Time High Change
-57.64%
All Time High Date
2018-09-17
All Time Low
140
All Time Low Change
1,004.29%
All Time Low Date
2007-09-13
ATR
57.69
Beta
-0.17
Beta1y
0.34
Beta2y
0.31
Ch YTD
-19.9
High
1,616
High52
2,644
High52 Date
2025-09-18
High52ch
-41.53%
Low
1,536
Low52
1,272.3
Low52 Date
2026-03-30
Low52ch
21.51%
Ma50ch
6.51%
Price vs 200-day SMA
-19.5%
RSI
58.85
RSI Monthly
41.78
RSI Weekly
41.63
Sharpe ratio
-0.23x
Sortino ratio
-0.2
Total Return
0.83%
Tr YTD
-19.05
Tr15y
268.78%
Tr1m
10.75%
Tr1w
1.31%
Tr3m
-0.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
GBX 20.6M
Operating Income Growth
9.45
Operating Income Growth Q
21.94
Operating Income Growth3 Y
10.79
Operating Income Growth5 Y
7.05
Operating margin
13.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
24,684,190%
Net Borrowing
-6,512,870.8
Shares Insiders
18.22%
Shares Institutions
73.38%
Shares Out
34,351,872
Shares Qo Q
-0.58%
Shares Yo Y
1.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
GBX 2.9M
Average Volume
256,973.4x
Bv Per Share
7.19
CAPEX
GBX -306,859
Ch10y
94.47
Ch15y
185.2
Ch1m
10.75
Ch1w
1.31
Ch1y
-14.59
Ch3m
-1.53
Ch3y
3.07
Ch5y
-43.27
Ch6m
-28.76
Change
-1.9%
Change From Open
-1.9
Close
1,576
Days Gap
0
Depreciation Amortization
1,665,810.3
Dollar Volume
315,404,098
Earnings Date
2026-05-29
EBIT
GBX 20.6M
EBITDA
GBX 22.3M
EPS
GBX 0.47
F Score
5
FCF
GBX 7.3M
FCF EV Yield
1.4x
FCF Per Share
GBX 0.21
Financing CF
-19,453,226
Fiscal Year End
June
Founded
1,999
Goodwill
172,548,899.3
Graham Number
896.054
Graham Upside
-42.04
Income Tax
GBX 3.3M
Investing CF
-11,345,610
Is Primary Listing
1
Last Earnings Date
2026-03-02
Last Report Date
2025-12-31
Lynch Fair Value
GBX 947
Lynch Upside
-38.75
Ma150
1,797.9
Ma150ch
-14.01%
Ma20
1,515.2
Ma20ch
2.03%
Net CF
-23,191,259
Next Earnings Date
2026-05-29
Open
1,576
P FCF Ratio
72.74
P OCF Ratio
69.81
Payment Date
2026-04-16
Position In Range
12.5
Ppne
4,035,060.5
Price Date
2026-05-08
Price EBITDA
GBX 23.81
Relative Volume
0.79x
Revenue
157,021,162x
SBC By Revenue
2.83x
Share Based Comp
4,442,397
Tax By Revenue
2.08x
Tax Rate
16.33%
Tr6m
-27.37%
Volume
204,013
Z Score
4.47
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

AIM/CRW dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.2%
$0.34 annual per share
Payout ratio
+66.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+4.4%
18 consecutive years of growth
Total shareholder yield
+0.8%
Next ex-dividend date: 2026-03-19
Performance

AIM/CRW stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-12.9%
S&P 500 1Y: n/a
3Y total return
+8.2%
S&P 500 3Y: n/a
5Y total return
-38.6%
S&P 500 5Y: n/a
10Y total return
+124.4%
S&P 500 10Y: n/a
Ownership

Who owns AIM/CRW?

Insider, institutional, and short-interest positioning.

Institutional ownership
+73.4%
Share of float held by funds and institutions
Insider ownership
+18.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.3%
Negative means the company is buying back shares.
Technical

AIM/CRW momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
58.8
Neutral momentum band
Price vs 200-day MA
-19.5%
50/200-day relationship not available
Beta (5Y)
-0.17
Less volatile than the market
Sharpe ratio
-0.23
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/CRW

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/CRW stock rating?

aim/CRW is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/CRW analysis?

The full report lives at /stocks/aim/CRW/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/CRW?

The latest report frames aim/CRW around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/CRW page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

aim/CRW stock profile: metrics, valuation and analysis | StockMarketAgent.AI